Upgrade to SI Premium - Free Trial

Evercore ISI Upgrades Intellia Therapeutics (NTLA) to Outperform

August 6, 2026 4:17 PM
Evercore ISI analyst Jonathan Miller upgraded Intellia Therapeutics (NASDAQ: NTLA) from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Hot Upgrades Upgrades